Literature DB >> 34843866

Recent advances in drug polymorphs: Aspects of pharmaceutical properties and selective crystallization.

Qin Shi1, Haibiao Chen2, Yanan Wang3, Jia Xu3, Ziying Liu3, Chen Zhang4.   

Abstract

Drug polymorphism, an established term used to describe the phenomenon that a drug can exist in different crystalline phases, has attracted great interests in pharmaceutical field in consideration of its important role in affecting the pharmaceutical performance of oral formulations. This paper presents an overview of recent advances in the research on polymorphic drug systems including understandings on nucleation, crystal growth, dissolution, mechanical properties, polymorphic transformation, etc. Moreover, new strategies and mechanisms in the control of polymorphic forms are also highlighted in this review. Furthermore, challenges and trends in the development of polymorphic drugs are briefly discussed, aiming at developing effective and efficient pharmaceutical formulations containing the polymorphic drugs.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crystallization; Polymorph control; Polymorphic drugs; Polymorphic transformation; Structure-properties relationship

Mesh:

Substances:

Year:  2021        PMID: 34843866     DOI: 10.1016/j.ijpharm.2021.121320

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Comparison of Paliperidone Palmitate from Different Crystallization Processes and Effect on Formulations In Vitro and In Vivo.

Authors:  Junfeng Shi; Dan Wang; Yang Tian; Zengming Wang; Jing Gao; Nan Liu; Xiang Gao; Aiping Zheng; Hui Zhang; Meixian Xiang
Journal:  Pharmaceutics       Date:  2022-05-20       Impact factor: 6.525

2.  Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process.

Authors:  Mac Arturo Murillo-Fernández; Ernesto Montero-Zeledón; Ariadna Abdala-Saiz; José Roberto Vega-Baudrit; Andrea Mariela Araya-Sibaja
Journal:  Pharmaceutics       Date:  2022-02-16       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.